AMGEN INC: Appeal From Dismissal of “Birch” Suit Remains Pending

Subscribe
TOPICS: Drugs/Pharmaceuticals | Earnings | Legal Issues, Litigation | Loans & Financing | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | United States